ANGEL Biotechnology Holdings has seen its half-year losses hit £2.86 million, due to the cost of setting up a joint venture.
The biomaterials manufacturer, which operates from the Edinburgh Science Park and a larger site at Cramlington in Northumberland, reported revenue of £1.07m in the six months to September 30. More than £2m of the loss was attributed to a write-back of revenue and contract liabilities associated with the proposed formation of a joint venture with long-term customer Materia Medica Holdings (MMH).
Angel had announced it would be booking the loss last week.
The deal, to make active antibody products for Russian firm MMH, was announced in October 2011, and was initially to be run from a dedicated space at Cramlington but there have been numerous delays.
The agreement is finally expected to be signed before the end of the month with the joint venture now at the Pentlands site.
Chairman Nicholas Smith said the business was also suffering because many current and prospective clients were seeing their funding restrained.
Staff numbers have been cut to 24 from 37 earlier in the year, and all non-essential spending pared back.
The company has changed its financial year so the most recent comparable half-year figures cover the period to June 30, 2011, when revenue was £1.4m and pre-tax loss £241,000.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article